250 related articles for article (PubMed ID: 36638937)
21. Circulating and Tumor Myeloid-derived Suppressor Cells in Resectable Non-Small Cell Lung Cancer.
Yamauchi Y; Safi S; Blattner C; Rathinasamy A; Umansky L; Juenger S; Warth A; Eichhorn M; Muley T; Herth FJF; Dienemann H; Platten M; Beckhove P; Utikal J; Hoffmann H; Umansky V
Am J Respir Crit Care Med; 2018 Sep; 198(6):777-787. PubMed ID: 29617574
[TBL] [Abstract][Full Text] [Related]
22. Roles of Myeloid-Derived Suppressor Cells in Cancer Metastasis: Immunosuppression and Beyond.
Pastaki Khoshbin A; Eskian M; Keshavarz-Fathi M; Rezaei N
Arch Immunol Ther Exp (Warsz); 2019 Apr; 67(2):89-102. PubMed ID: 30386868
[TBL] [Abstract][Full Text] [Related]
23. Recruited monocytic myeloid-derived suppressor cells promote the arrest of tumor cells in the premetastatic niche through an IL-1β-mediated increase in E-selectin expression.
Shi H; Zhang J; Han X; Li H; Xie M; Sun Y; Liu W; Ba X; Zeng X
Int J Cancer; 2017 Mar; 140(6):1370-1383. PubMed ID: 27885671
[TBL] [Abstract][Full Text] [Related]
24. Inhibiting myeloid-derived suppressor cell trafficking enhances T cell immunotherapy.
Sun L; Clavijo PE; Robbins Y; Patel P; Friedman J; Greene S; Das R; Silvin C; Van Waes C; Horn LA; Schlom J; Palena C; Maeda D; Zebala J; Allen CT
JCI Insight; 2019 Apr; 4(7):. PubMed ID: 30944253
[TBL] [Abstract][Full Text] [Related]
25. Targeting Myeloid-Derived Suppressor Cells for Premetastatic Niche Disruption After Tumor Resection.
Tang F; Tie Y; Hong W; Wei Y; Tu C; Wei X
Ann Surg Oncol; 2021 Jul; 28(7):4030-4048. PubMed ID: 33258011
[TBL] [Abstract][Full Text] [Related]
26. XIAOPI formula inhibits the pre-metastatic niche formation in breast cancer via suppressing TAMs/CXCL1 signaling.
Zheng Y; Wang N; Wang S; Yang B; Situ H; Zhong L; Lin Y; Wang Z
Cell Commun Signal; 2020 Mar; 18(1):48. PubMed ID: 32213179
[TBL] [Abstract][Full Text] [Related]
27. ΔNp63-driven recruitment of myeloid-derived suppressor cells promotes metastasis in triple-negative breast cancer.
Kumar S; Wilkes DW; Samuel N; Blanco MA; Nayak A; Alicea-Torres K; Gluck C; Sinha S; Gabrilovich D; Chakrabarti R
J Clin Invest; 2018 Nov; 128(11):5095-5109. PubMed ID: 30295647
[TBL] [Abstract][Full Text] [Related]
28. Complement C5a induces the formation of neutrophil extracellular traps by myeloid-derived suppressor cells to promote metastasis.
Ortiz-Espinosa S; Morales X; Senent Y; Alignani D; Tavira B; Macaya I; Ruiz B; Moreno H; Remírez A; Sainz C; Rodriguez-Pena A; Oyarbide A; Ariz M; Andueza MP; Valencia K; Teijeira A; Hoehlig K; Vater A; Rolfe B; Woodruff TM; Lopez-Picazo JM; Vicent S; Kochan G; Escors D; Gil-Bazo I; Perez-Gracia JL; Montuenga LM; Lambris JD; Ortiz de Solorzano C; Lecanda F; Ajona D; Pio R
Cancer Lett; 2022 Mar; 529():70-84. PubMed ID: 34971753
[TBL] [Abstract][Full Text] [Related]
29. Atovaquone Suppresses Triple-Negative Breast Tumor Growth by Reducing Immune-Suppressive Cells.
Gupta N; Gaikwad S; Kaushik I; Wright SE; Markiewski MM; Srivastava SK
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34068008
[TBL] [Abstract][Full Text] [Related]
30. Role of myeloid-derived suppressor cells in tumor recurrence.
Cole K; Al-Kadhimi Z; Talmadge JE
Cancer Metastasis Rev; 2023 Mar; 42(1):113-142. PubMed ID: 36640224
[TBL] [Abstract][Full Text] [Related]
31. Suppression of T cells by myeloid-derived suppressor cells in cancer.
Chen J; Ye Y; Liu P; Yu W; Wei F; Li H; Yu J
Hum Immunol; 2017 Feb; 78(2):113-119. PubMed ID: 27939507
[TBL] [Abstract][Full Text] [Related]
32. The Role of Myeloid-Derived Suppressor Cells in Tumor Growth and Metastasis.
Bayik D; Lee J; Lathia JD
Exp Suppl; 2022; 113():189-217. PubMed ID: 35165865
[TBL] [Abstract][Full Text] [Related]
33. Polymorphonuclear-MDSCs Facilitate Tumor Regrowth After Radiation by Suppressing CD8
Zhang Md J; Zhang Md L; Yang Md Y; Liu Md Q; Ma Md H; Huang Md A; Zhao Md Y; Xia Md Z; Liu Md T; Wu Md G
Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1533-1546. PubMed ID: 33238192
[TBL] [Abstract][Full Text] [Related]
34. Neutralization of IL-8 decreases tumor PMN-MDSCs and reduces mesenchymalization of claudin-low triple-negative breast cancer.
Dominguez C; McCampbell KK; David JM; Palena C
JCI Insight; 2017 Nov; 2(21):. PubMed ID: 29093275
[TBL] [Abstract][Full Text] [Related]
35. Endoplasmic reticulum stress mediates the myeloid-derived immune suppression associated with cancer and infectious disease.
Lou X; Gao D; Yang L; Wang Y; Hou Y
J Transl Med; 2023 Jan; 21(1):1. PubMed ID: 36593497
[TBL] [Abstract][Full Text] [Related]
36. Transcriptomic profiling disclosed the role of DNA methylation and histone modifications in tumor-infiltrating myeloid-derived suppressor cell subsets in colorectal cancer.
Sasidharan Nair V; Saleh R; Toor SM; Taha RZ; Ahmed AA; Kurer MA; Murshed K; Alajez NM; Abu Nada M; Elkord E
Clin Epigenetics; 2020 Jan; 12(1):13. PubMed ID: 31941522
[TBL] [Abstract][Full Text] [Related]
37. Multimodal Intralesional Therapy for Reshaping the Myeloid Compartment of Tumors Resistant to Anti-PD-L1 Therapy via IRF8 Expression.
Patel A; Oba T; Kajihara R; Yokoi T; Abrams SI; Ito F
J Immunol; 2021 Sep; 207(5):1298-1309. PubMed ID: 34362833
[TBL] [Abstract][Full Text] [Related]
38. Inflammation-Driven Nanohitchhiker Enhances Postoperative Immunotherapy by Alleviating Prostaglandin E2-Mediated Immunosuppression.
Liu Y; He J; Li M; Ren K; Zhao Z
ACS Appl Mater Interfaces; 2024 Feb; 16(6):6879-6893. PubMed ID: 38300288
[TBL] [Abstract][Full Text] [Related]
39. Myeloid-derived suppressor cells-new and exciting players in lung cancer.
Yang Z; Guo J; Weng L; Tang W; Jin S; Ma W
J Hematol Oncol; 2020 Jan; 13(1):10. PubMed ID: 32005273
[TBL] [Abstract][Full Text] [Related]
40. MDSCs in breast cancer: an important enabler of tumor progression and an emerging therapeutic target.
Liu H; Wang Z; Zhou Y; Yang Y
Front Immunol; 2023; 14():1199273. PubMed ID: 37465670
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
